Quarterly report pursuant to Section 13 or 15(d)

Accrued expenses and other liabilities

v3.20.2
Accrued expenses and other liabilities
 9 Months Ended
Sep. 30, 2020
Accrued expenses and other liabilities.  
Accrued expenses and other liabilities

8. Accrued Expenses and Other Liabilities

Accrued expenses and other liabilities consist of the following:

 

 

 

 

 

 

 

 

 

 

September 30, 

 

December 31, 

 

    

2020

    

2019

Accrued preclinical and clinical trial expenses

 

$

627,604

 

$

1,156,618

Compensation and related benefits

 

 

186,363

 

 

303,870

Other expenses

 

 

689,932

 

 

215,979

 

 

$

1,503,899

 

$

1,676,467